COMPANY

Haima Therapeutics

HQ: Cleveland, OH source · haimatherapeutics.com ↗ · Midwest

Location: Cleveland, OH · source · Oct 14, 2026

Profile checked Oct 10, 2026

4NIH grants

Funding and NIH signals

NIH award NIH awarded $500K (SBIR commercialization 1SB1HL184353-01, new, notice Sep 17, 2026); 3 NIH awards totaling $1.53M in the last 12 months. NIH RePORTER 1SB1HL184353-01 (Sep 17, 2026)
Evidence (3 events)
- Sep 17, 2026 · NIH RePORTER 1SB1HL184353-01
  Organization: HAIMA THERAPEUTICS, LLC; City/State: CLEVELAND, OH; Project number: 1SB1HL184353-01; Activity code: SB1; Fiscal year: 2026; Award notice date: 2026-09-17; FY total cost (award amount): 499999; Administering IC: National Heart Lung and Blood Institute; Project title: Commercialization Strategy for an Intravenous Hemostatic Nanotechnology for Bleeding Management; Organization type: Domestic For-Profits
- Aug 14, 2026 · NIH RePORTER 3R44HL180258-02S1
  Organization: HAIMA THERAPEUTICS, LLC; City/State: CLEVELAND, OH; Project number: 3R44HL180258-02S1; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-14; FY total cost (award amount): 50000; Administering IC: National Heart Lung and Blood Institute; Project title: A Novel Platelet-Inspired Nanotechnology to Restore Hemostasis in Patients on Antiplatelet Agents; Organization type: Domestic For-Profits
- Aug 4, 2026 · NIH RePORTER 5R44HL180258-02
  Organization: HAIMA THERAPEUTICS, LLC; City/State: CLEVELAND, OH; Project number: 5R44HL180258-02; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-04; FY total cost (award amount): 978218; Administering IC: National Heart Lung and Blood Institute; Project title: A Novel Platelet-Inspired Nanotechnology to Restore Hemostasis in Patients on Antiplatelet Agents; Organization type: Domestic For-Profits

Job counts as of Oct 18, 2026. All funding and NIH signals

Timeline

Sep 17, 2026 Grant Government grant — SBIR: $499,999 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Aug 14, 2026 Grant Government grant — SBIR: $50,000 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Aug 4, 2026 Grant Government grant — SBIR: $978,218 (annual award, as published), announced Aug 4, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 11, 2025 Grant Government grant — SBIR: $944,676 (annual award, as published), announced Jul 11, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Apr 1, 2025 Grant Government grant — SBIR: $50,000 (annual award, as published), announced Apr 1, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

Funding

Last 2 years.

Sep 17, 2026 Government grant — SBIR: $499,999 (annual award, as published), announced Sep 17, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Aug 14, 2026 Government grant — SBIR: $50,000 (annual award, as published), announced Aug 14, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Aug 4, 2026 Government grant — SBIR: $978,218 (annual award, as published), announced Aug 4, 2026. Agency: NIH/NHLBI. Source: government award database. source ↗
Jul 11, 2025 Government grant — SBIR: $944,676 (annual award, as published), announced Jul 11, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗
Apr 1, 2025 Government grant — SBIR: $50,000 (annual award, as published), announced Apr 1, 2025. Agency: NIH/NHLBI. Source: government award database. source ↗

NIH awards 4

Annual award amounts. Total $2.4M.

Jun 6, 2024 NIH award 3R44HL145948-03S1 FY2024: $112,804 awarded for that fiscal year; activity R44 (SBIR); PI BRUCKMAN, MICHAEL ARTHUR; recipient as written: HAIMA THERAPEUTICS, LLC, CLEVELAND, OH. SynthoPlate: Intravenous Hemo source ↗
May 20, 2024 NIH award 5R44HL145948-03 FY2024: $972,163 awarded for that fiscal year; activity R44 (SBIR); PI BRUCKMAN, MICHAEL ARTHUR; recipient as written: HAIMA THERAPEUTICS, LLC, CLEVELAND, OH. SynthoPlate: Intravenous Hemost source ↗
Jun 1, 2023 NIH award 2R44HL145948-02 FY2023: $994,448 awarded for that fiscal year; activity R44 (SBIR); PI BRUCKMAN, MICHAEL ARTHUR; recipient as written: HAIMA THERAPEUTICS, LLC, CLEVELAND, OH. SynthoPlate: Intravenous Hemost source ↗
May 24, 2019 NIH award 1R43HL145948-01 FY2019: $299,935 awarded for that fiscal year; activity R43 (SBIR); PI BRUCKMAN, MICHAEL ARTHUR; recipient as written: HAIMA THERAPEUTICS, LLC, CLEVELAND, OH. SynthoPlate: Intravenous Hemost source ↗